Alcyone Therapeutics Continues PIERRE Study Enrollment For ThecaFlex
31 Jul 2024 //
PR NEWSWIRE
Alcyone Appoints Riedel As Chairman, Meyer As CSO And Head Of R&D
08 May 2024 //
PR NEWSWIRE
Alcyone Receives FDA IDE Approval to Clinical Study ThecaFlex DRxTM of SPINRAZA
27 Jun 2023 //
PR NEWSWIRE
Alcyone Announces Two Oral Presentations on its Gene Therapy Platforms at ASGCT
02 May 2022 //
PRNEWSWIRE